BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0

Historical Portfolio Holders from Q3 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 0.599% 8/0
Principal, excl. options Q1 2024
407 M
Holdings value Q1 2024
$403 M
Value change Q1 2024
+$18.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
53
Number of buys Q1 2024
22
Number of sells Q1 2024
-25
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
09061GAH4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $407 M $403 M +$18.1 M $0.98 53
2023 Q4 $388 M $385 M +$38.7 M $0.99 58
2023 Q3 $351 M $347 M -$20.3 M $0.97 58
2023 Q2 $386 M $382 M -$15.1 M $0.98 56
2023 Q1 $396 M $412 M +$49.8 M $1.03 55
2022 Q4 $353 M $379 M +$41.9 M $1.06 53
2022 Q3 $292 M $268 M -$52.3 M $0.99 45
2022 Q2 $362 M $318 M -$11.2 M $0.99 48
2022 Q1 $372 M $349 M +$28.1 M $1.00 47
2021 Q4 $343 M $333 M -$42.3 M $1.05 44
2021 Q3 $387 M $399 M -$3.32 M $1.03 45
2021 Q2 $394 M $480 M -$49.3 M $1.04 42
2021 Q1 $463 M $474 M +$19.7 M $1.02 46
2020 Q4 $444 M $452 M +$7.79 M $1.07 49
2020 Q3 $430 M $435 M +$1.46 M $1.05 47
2020 Q2 $423 M $504 M +$29.9 M $1.22 52
2020 Q1 $422 M $402 M +$62.4 M $1.04 47
2019 Q4 $370 M $343 M -$99.1 M $1.06 48
2019 Q3 $483 M $418 M -$3.37 M $0.98 42
2019 Q2 $490 M $442 M +$22.3 M $1.04 44
2019 Q1 $470 M $414 M -$18.7 M $1.02 46
2018 Q4 $492 M $423 M +$24.6 M $0.99 42
2018 Q3 $474 M $425 M +$47.8 M $1.06 43
2018 Q2 $393 M $862 M +$17.2 M $1.01 37
2018 Q1 $396 M $793 M +$424 M $0.94 39
2017 Q4 $404 M $374 M +$10.1 M $1.00 46
2017 Q3 $401 M $369 M +$369 M $1.01 40